Search Results for 'Drug Development'
Contract Service Directory Companies
Microsite Companies
Featured Companies
View All Buyers Guide Companies »
Contract Service Directory Categories
View All Categories »
-
Breaking News | Collaborations & Alliances | Drug Development | Industry News | Solid Dosage/Creams/Ointments
Pfizer Partners with Medicines Manufacturing Innovation Center
To transform the formulation of oral solid dosage medicines.Tim Wright, Editor, Contract Pharma 02.25.21
-
Breaking News | Drug Development | Industry News
Cyprium, Sentynl Therapeutics Ink Asset Purchase Agreement
Sentynl acquires CUTX-101 Copper Histidinate for the treatment of Menkes disease for $20 million in upfront and regulatory milestones.Kristin Brooks 02.24.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News | Information Technology
Pfizer Selects Seven Bridges to Support RNA Sequencing Data
Seven Bridges will centralize and manage terabytes scRNASeq data, which provides detailed analysis of gene expression in individual cells.Kristin Brooks 02.24.21
-
Breaking News | Drug Development | Promotions & Moves
Aevitas Therapeutics Appoints President and CEO
Dr. Markus Peters offers a 25-year track record of developing and commercializing orphan and specialty pharmaceuticals.Charles Sternberg, Assistant Editor 02.22.21
-
Drug Development
Embedding Your Drug Strategy Within a Solid Foundation for Success
This whitepaper looks at the broad set of trends influencing pharmaceutical development and manufacturing strategy today.
-
Breaking News | Collaborations & Alliances | Drug Development
Lilly, Rigel Enter Exclusive CNS Development Collaboration
Lilly will pay $125 million upfront and up to $835 million in potential milestones for Rigel's lead RIPK1 inhibitor, R552.Kristin Brooks 02.18.21
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development
Biomunex, Onward Ink Strategic Antibody Development Pact
Exclusive worldwide license and development agreement will leverage Biomunex' next gen bi- and multi-specific antibody platform in hematological malignancies.Kristin Brooks 02.16.21
-
APIs | Breaking News | Drug Development | Formulation Development | Industry News | Solid Dosage/Creams/Ointments
Lonza Expands Solid Small Molecule Services
To encompass all aspects of solid form screening and characterization of small molecule APIs.Kristin Brooks 02.16.21
-
Biologics, Proteins, Vaccines | Collaborations & Alliances | Drug Development
Molecular Templates, BMS Enter Strategic Research Pact
Aims to discover and develop multiple therapies for specific oncology targets utilizing MTEM’s next-gen engineered toxin body (ETB) platform.Kristin Brooks 02.11.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Industry News
AbbVie, Caribou Ink CAR-T Collaboration
Leverages Caribou's next-generation CRISPR genome editing technology platform and AbbVie's antigen-specific binders.Tim Wright, Editor, Contract Pharma 02.10.21
-
Breaking News | Drug Development | Industry News | Laboratory Testing
Quotient Sciences Acquires Arcinova
Acquisition expands Quotient’s services with drug substance, drug product and clinical testing capabilities.Kristin Brooks 02.09.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Paragon Biosciences Expands Cell and Gene Therapy Platform
Launches CiRC Biosciences with an initial focus on developing eye disease treatments.Tim Wright, Editor, Contract Pharma 02.08.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Trials & Filings
J&J Submits EUA for Single-Shot Janssen COVID Vax Candidate
Plans to distribute vaccine to U.S. government immediately following authorization, and expects to supply 100 million doses in 1H21.Kristin Brooks 02.05.21
-
Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development
The Future of Vaccines and Biologics
Dr. Linda Marbán of Capricor Therapeutics discusses the advances in responding to infectious diseases.Online Exclusives Kristin Brooks, Managing Editor, Contract Pharma 02.04.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Trials & Filings
Vaxart Oral COVID-19 Vax Tablet Shows Promise
Phase I study reached primary and secondary endpoints of safety and immunogenicity.Kristin Brooks 02.03.21
-
Breaking News | Clinical Trials | Drug Development | Industry News
Affimed, Roche Explore AFM24, Tecentriq Combo
To investigate the combination for the treatment of advanced solid epidermal growth factor receptor (EGFR) expressing malignancies.Kristin Brooks 02.03.21
-
Breaking News | Collaborations & Alliances | Drug Development
Imcyse, Pfizer Enter Autoimmune Research Alliance
Will develop Imotope candidates to potentially treat Rheumatoid Arthritis.Charles Sternberg, Assistant Editor 02.03.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Clinical Trial Materials | Clinical Trials | Drug Development | Industry News
Immunome, Abzena Enter COVID-19 Antibody Cocktail Agreement
Abzena will work with Immunome to produce the antibody cocktail for clinical testing.Kristin Brooks 02.03.21
-
cGMP Manufacture | Drug Development | Process Development | R&D
Importance of Green Chemistry in Drug Development And Manufacturing
Learn how one CDMO is at the forefront of green chemistry, applying its principles to reduce the environmental and human impact of pharmaceutical production.
-
Breaking News | Clinical Trials | Drug Development | Industry News
DoD Awards Rigel $16.5M to Support Fostamatinib COVID Trials
Will evaluate the safety and efficacy of fostamatinib in hospitalized COVID-19 patients without respiratory failure.Kristin Brooks 02.01.21
-
Breaking News | Drug Development | Industry News
Lilly Acquires Asahi Kasei’s Chronic Pain Candidate
To pay $20 million upfront and up to $210 million in potential milestones for AK1780, an orally bioavailable P2X7 receptor antagonist.Kristin Brooks 02.01.21
-
Breaking News | Drug Development | Industry News
Gilead, Gritstone Enter Vax Platform Pact for HIV Cure
Aims to develop HIV-specific vaccine using Gritstone’s prime-boost vaccine platform with antigens developed by Gilead.Kristin Brooks 02.01.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Industry News | Information Technology
Cognate BioServices, Nucleus Biologics Form Cell & Gene Therapy Partnership
Will focus on clinical and commercial clients, especially as Cognate expands its business with allogeneic and autologous on-demand cell and gene therapies.Tim Wright, Editor, Contract Pharma 01.29.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Drug Discovery | Industry News | Information Technology
Evozyne, Takeda Ink Strategic Protein Design Agreement
Takeda will use Evozyne's evolution-based protein design technology to research and develop proteins for next-gen gene therapies.Kristin Brooks 01.28.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Lonza Launches Cryopreserved Leukopaks
Customizable cryopreserved Leukopaks aim to provide greater flexibility in immunology and cell therapy research.Kristin Brooks 01.28.21
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development
Lilly, Vir, GSK Partner to Evaluate COVID Combo Therapies
Lilly expands BLAZE-4 trial to evaluate bamlanivimab with VIR-7831, two neutralizing antibodies that bind to different epitopes of the SARS-CoV-2 spike protein.Kristin Brooks 01.27.21
-
Breaking News | Clinical Trials | Drug Development | Industry News | Laboratory Testing
Caprion-HistoGeneX Rebrands as CellCarta
Recently expanded its scientific capabilities and geographic presence with the acquisitions of Clinical Logistics Inc. and Mosaic Laboratories.Kristin Brooks 01.26.21
-
Breaking News | Drug Development | Drug Discovery | Industry News
Lilly Completes $1B Acquisition of Prevail
Adds new modality for drug discovery and development and creates a gene therapy program with neuroscience assets.Kristin Brooks 01.22.21
-
Breaking News | Drug Development | Industry News | Information Technology | Regulatory Affairs
Top BioPharma Form Accumulus Synergy
Aims to develop a cloud-based Global Data Sharing Platform to facilitate data and information sharing between industry and health authorities worldwide.Kristin Brooks 01.22.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
AbbVie Licenses ProBioGen’s GlymaxX Technology
Will apply GlymaxX technology to boost the antibody-dependent cell-mediated cytotoxicity (ADCC).Kristin Brooks 01.22.21
-
Drug Development
Drug Development For Startups
There is no way to eliminate the risk of failure. However, there are ways to reduce these risks. Learn more in this whitepaper from Recipharm.
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
Janssen, TenNor Enter NTM Research Pact
To leverage TenNor’s multitargeting drug conjugation platform to discover new therapies to treat nontuberculous mycobacteria diseases.Contract Pharma Staff 01.18.21
-
Clinical Trials | Drug Development | Information Technology
Virtual Clinical Trials: The Future of Dermatology Studies
COVID-19 has created lasting impacts for clinical trials and a host of benefits have arisen from the adoption of virtual and hybrid models.Sonja VanWye, RN, MSN, Director, Dermatology Strategy, IQVIA Biotech 01.15.21
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
EVOQ Therapeutics and Amgen Partner
Collaborate on the discovery and development of novel drugs for autoimmune disorders.Contract Pharma Staff 01.13.21
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development
Adagene Achieves CAR-T Collaboration Milestone
Yields potential first-ever antibodies targeting human endogenous retrovirus associated with kidney cancer.Contract Pharma Staff 01.12.21
-
Analytical Services | Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development | Fill/Finish
A New Era of Vaccine and Biologic Drug Development
As a result of COVID-19, unprecedented investments in vaccines, diagnostics, and treatments have had a tremendous impact on the Biotechnology industry.Online Exclusives Kristin Brooks, Managing Editor 01.12.21
-
Bio News | Breaking News | Collaborations & Alliances | Drug Development | Industry News
Cyclolab and EpiPharma Form Joint Venture
Will develop and commercialize Peptide drug candidates for the treatment of debilitating CNS and Pulmonary diseases.Contract Pharma Staff 01.11.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News | Laboratory Testing
Biohaven Acquires Remaining Stake in Kleo Pharmaceuticals
Enters exclusive license agreement with Yale University for a novel extracellular degrader technology licensed from Spiegel Lab.Contract Pharma Staff 01.08.21
-
Clinical Trials | Drug Development
The Slow – But Desperately Needed – Evolution of Oncology Clinical Development Designs
Appropriate adaptive designs in early stages of development can accelerate timelines and reduce costs, and help focus on the most promising agents.Jürgen Hummel, MSc, Senior Director, Statistical Science, PPD, and Lead of PPD’s Adaptive Design Working Group 01.07.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
BrickBio Inks ADC Co-Development Deal
To co-develop a therapeutic antibody drug conjugate (ADC) with a large pharmaceutical company.Contract Pharma Staff 01.06.21
-
Drug Development | Industry News | Regulatory Affairs
The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
A look at EUA standards and approvals, unavoidable pitfalls, Operation Warp Speed, FDA’s use of Real-World Evidence, and a slow return to "normalcy".Chad Landmon, Michelle Divelbiss and Alex Alfano, Axinn, Veltrop & Harkrider LLP's Intellectual Property and Food and Drug Administration Practice Groups 01.05.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News | Information Technology
Lantern Pharma Launches ADC Program
Will leverage RADR artificial intelligence platform to target solid tumors and blood cancers through agreement with Califia Pharma.Contract Pharma Staff 01.04.21
-
Clinical Trials | Drug Development
Impact of Decentralized Trials in Oncology Drug Development
Join us on 2/9 as clinical, regulatory and real-world evidence experts discuss the impact of decentralized trials on the evolution of drug dev in oncology.01.04.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Chemistry | Drug Development | Industry News
Oncorus to Build GMP Viral Immunotherapy Mfg. Facility
88,000 sq.-ft. facility in Andover, MA will support multi-product pipeline of intratumorally and intravenously administered viral immunotherapies.Contract Pharma Staff 01.04.21
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
Evotec, BMS Advance Targeted Protein Degradation Projects
The first two targets transition into drug discovery after completing a comprehensive target validation process.Contract Pharma Staff 12.17.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
INOVIO to Develop dMAb COVID Treatments under DARPA Grant
$37.6 million grant will leverage AstraZeneca's monoclonal antibody and INOVIO's dMAb technologies in the fight against COVID-19.Contract Pharma Staff 12.15.20
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Lilly to Acquire Prevail Therapeutics in $1B Deal
Adds a new drug discovery and development modality and creates a gene therapy program anchored by Prevail's portfolio of neuroscience assets.Contract Pharma Staff 12.15.20
-
Breaking News | Clinical Trials | CRO News | Drug Development
Ergomed Acquires MedSource
Specialist oncology and rare disease CRO further expands Ergomed’s presence in the U.S. market.Contract Pharma Staff 12.15.20
-
Clinical Trials | Drug Development | Information Technology
Advancing Digital Endpoints in Clinical Trials
An end-to-end approach to managing wearable devices through clinical development.Online Exclusives Kristin Brooks, Contract Pharma 12.14.20
-
Clinical Trials | Drug Development | Information Technology
Advances in Intelligent Automation
The future of medicine relies on further digital transformation and automation-enabling solutions to improve drug development and monitoring.Updesh Dosanjh, Practice Leader, Technology Solutions, IQVIA 12.14.20
